Are late complications of Parkinson’s disease really late? YES

Published in: Cesk Slov Neurol N 2019; 82(3): 265
Category: Controversions


1. Postuma RB, Berg D, Stern M et al. MDS clinical dia­g­nostic criteria for Parkinson’s disease. Mov Disord 2015; 30(12): 1591–1601. doi: 10.1002/mds.26424.

2. Henner K. Speclní neurologie. Praha: Státní zdravotnické nakladatelství 1953.

3. Lopez CI, Ruiz PJ, Del Pozo SV et al. Motor complications in Parkinsonś disease: ten year follow up study. Mov Disord 2010; 25(16): 2735–2739. doi: 10.1002/mds.23219.

4. Warren Olanow C, Kieburtz K, Rascol O et al. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinsonś disease. Mov Disord 2013; 28(8): 1064–1071. doi: 10.1002/mds.25364.

5. Szatmari S, Illigens BM, Siepmann T et al. Neuropsychiatric symptoms in untreated Parkinsonś disease. Neuropsychiatr Dis Treat 2017; 13: 815–826. doi: 10.2147/NDT.S130997.

6. Weintraub D, Tröster AI, Marras C et al. Initial cognitive changes in Parkinsonś disease. Mov Disord 2018; 33(4): 511–519. doi: 10.1002/mds.27330.

7. Rajput AH. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism Relat Disord 2001; 8(2): 95–100.

8. Postuma RB, Berg D. Advances in markers of prodromal Parkinsonś disease. Nat Rev Neurol 2016; 12(11): 622–634. doi: 10.1038/nrneurol.2016.152.

Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 3

2019 Issue 3

Most read in this issue
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account